Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.
Journal: JAMA network open
Published: July 14, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.
Journal: Substance use & misuse
Published: April 03, 2026
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone.
Journal: Journal of addiction medicine
Published: August 12, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Journal: Journal of substance use and addiction treatment
Published: July 24, 2025
Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone.
Journal: The American journal of drug and alcohol abuse
Published: July 11, 2025
Opioid Use Disorder Outcomes Following Inpatient Opioid Withdrawal Management.
Journal: Journal of addiction medicine
Published: June 20, 2025
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data.
Journal: Addiction (Abingdon, England)
Published: September 17, 2024
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset.
Journal: Addiction (Abingdon, England)
Published: September 10, 2024
Machine Learning-Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention.
Journal: Journal of addiction medicine
Published: May 22, 2024
Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial.
Journal: Drug and alcohol dependence
Published: May 01, 2024
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD).
Journal: Contemporary clinical trials
Published: March 28, 2024
Last Updated: 09/26/2026